Free Trial

Patrick R. Analyst Performance

Analyst at HC Wainwright

Patrick R. is a stock analyst at HC Wainwright in the medical sector, covering 11 publicly traded companies. Over the past year, Patrick R. has issued 12 stock ratings, including and buy recommendations. While full access to Patrick R.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick R.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 0 Years
Buy Recommendations
100.00% 12 Buy Ratings
Companies Covered
11 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%12 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.9% of companies on NASDAQ
10 companies
NYSE
9.1% of companies on NYSE
1 company

Patrick R., an analyst at HC Wainwright, currently covers 11 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
11 companies
100.0%

Patrick R. of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
72.7%
MED - DRUGS
2 companies
18.2%
MED - OUTP/HM CRE
1 company
9.1%

Patrick R.'s Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
10/1/2025Reiterated Rating$3.30$40.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
9/25/2025Lower Price Target$26.76$55.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/24/2025Reiterated Rating$39.80$70.00Buy
atai Life Sciences N.V. stock logo
ATAI
atai Life Sciences
9/23/2025Reiterated Rating$5.36$15.00Buy
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
9/16/2025Reiterated Rating$4.73$75.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
9/15/2025Reiterated Rating$20.60$80.00Buy
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
9/15/2025Reiterated Rating$4.18$30.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
9/15/2025Reiterated Rating$48.75$85.00Buy
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
9/15/2025Reiterated Rating$4.80$15.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
9/12/2025Reiterated Rating$10.31$50.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
8/18/2025Initiated Coverage$7.70$50.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
8/18/2025Reiterated Rating$3.30$10.00Buy